3 completed, 1 terminated, 1 unknown. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 1, Unknown 1 |
Follow Palmar Hyperhidrosis: new trials by email Literature Review of Palmar Hyperhidrosis trials Research Report on Palmar Hyperhidrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy TTB gel (dose 1), TTB gel (dose 2), Placebo - Palmar Hyperhidrosis | Phase 2 | Terminated | Dryox Health | 58 | 2024-04-29 | 2025-06-22 |
| An Open Label Study for Palmar Hyperhydrosis Glycopyrronium 2.4 % Medicated Cloth - Palmar Hyperhidrosis, Hyperhidrosis | Phase 2 | Completed | Pariser, Robert J., M.D. | 120 | 2020-10-01 | 2021-05-28 |
| Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis Dexmecamylamine HCl, Placebo - Hyperhidrosis, Palmar Hyperhidrosis | Phase 2 | Unknown | Atacama Therapeutics | 75 | 2020-01-31 | 2021-07-22 |
| A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis Glycopyrronium cloth, 2.4%, Vehicle - Palmar Hyperhidrosis | Phase 2 | Completed | Journey Medical Corporation | 72 | 2019-02-22 | 2021-08-25 |
| Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis Dexmecamylamine HCl, Placebo - Palmar Hyperhidrosis | Phase 2 | Completed | Atacama Therapeutics | 60 | 2017-12-21 | 2019-11-21 |
Hyperhidrosis (3) · Sweat Gland Diseases (2) · Skin Diseases (1)
Skin and Connective Tissue Diseases (3) · Skin Diseases (2) · Sweat Gland Diseases (1)
Glycopyrrolate (1) · glycopyrronium tosylate (1)
Atacama Therapeutics (2) · Dryox Health (1) · Journey Medical Corporation (1) · Pariser, Robert J., M.D. (1)
United States (4) · Spain (1)
Clara Matas Nada, MD (1) · David M Pariser, MD (1) · Enrique Herrera Acosta, MD (1) · Kate Doherty (1)
2023 (1)